Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.42 |
| ▸ | KLK7 | P49862 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4250581 | 0.84 | KMT2A (0.58) | KMT2AMAPTALDH1A1LMNAHSD17B10 | |
| SCHEMBL9839367 | 0.81 | MAPT (0.50) | KMT2AMAPTALDH1A1LMNAHSD17B10 | |
| SCHEMBL4268398 | 0.81 | CYP4F2 (0.51) | KMT2AMAPTALDH1A1LMNAMEN1 | |
| SCHEMBL7220225 | 0.80 | KMT2A (0.49) | KMT2AMAPTALDH1A1LMNAHSD17B10 | |
| SCHEMBL16728392 | 0.79 | TAS1R3 (0.65) | KMT2AMAPTALDH1A1LMNAMEN1 | |
| SCHEMBL11402555 | 0.79 | TAS1R3 (0.65) | KMT2AMAPTALDH1A1LMNAMEN1 | |
| SCHEMBL9063033 | 0.79 | CYP1A2 (0.59) | KMT2AMAPTALDH1A1HSD17B10MEN1 | |
| SCHEMBL832097 | 0.78 | KMT2A (0.52) | KMT2AMAPTALDH1A1LMNAHTT | |
| SCHEMBL8431462 | 0.78 | KMT2A (0.52) | KMT2AMAPTALDH1A1LMNAHSD17B10 | |
| SCHEMBL14122122 | 0.78 | KMT2A (0.66) | KMT2AMAPTALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-20060173065-A1 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC | 2006-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173065-A1 | Functionalized phenolic esters and amides and polymers therefrom | HAAO, HAO2, HCAR3 | KMT2A 2066/4885MAPT 3480/4885ALDH1A1 132/4885 |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | HAO2, HCAR2, HAAO | KMT2A 1798/4885MAPT 3453/4885ALDH1A1 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.